Search for: "Novartis Pharmaceuticals Corp. v. Abbott Laboratories, Inc."
Results 21 - 40
of 45
Sort by Relevance
|
Sort by Date
14 Jul 2010, 6:47 pm
Sun Pharmaceutical Industries, Inc. [read post]
17 Jun 2010, 6:47 am
Abbott Laboratories, Inc. [read post]
27 May 2010, 3:20 am
Idexx Reference Laboratories, Inc. et al.; Pieczenik v. [read post]
13 May 2010, 4:58 pm
Barr Laboratories, Inc. [read post]
13 May 2010, 12:27 pm
Novartis Pharmaceuticals Corp., 642 F. [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
18 Nov 2009, 4:57 am
Corp. v. [read post]
18 Nov 2009, 4:57 am
Corp. v. [read post]
18 Nov 2009, 4:57 am
Corp. v. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
6 Aug 2009, 6:50 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
22 Jan 2009, 2:06 am
Alad Corp., 19 Cal.3d 22, 31 (1977). [read post]
2 Oct 2008, 12:36 pm
Novartis Pharmaceuticals Corp., 283 F.3d 254, 266-68 (5th Cir. 2002), where the court didn't let the plaintiff get away with arguing that there should have been a warning about "liver failure" and "death" in addition to "hepatitis. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
